Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anlotinib in patients with medullary thyroid carcinoma with negative prognostic factors: A sub-analysis based on the ALTER01031 study.
Zhao J, Chi Y, Hu C, Chen X, Ge M, Zhang Y, Guo Z, Wang J, Chen J, Zhang J, Cheng Y, Li Z, Liu H, Qin J, Zhu J, Cheng R, Xu Z, Li D, Tang P, Gao M, Zheng X. Zhao J, et al. Among authors: guo z. Front Oncol. 2022 Nov 22;12:852032. doi: 10.3389/fonc.2022.852032. eCollection 2022. Front Oncol. 2022. PMID: 36483043 Free PMC article.
Expert consensus statement on parathyroid protection in thyroidectomy.
Zhu J, Tian W, Xu Z, Jiang K, Sun H, Wang P, Huang T, Guo Z, Zhang H, Liu S, Zhang Y, Cheng R, Zhao D, Fan Y, Li X, Qin J, Zhao W, Su A. Zhu J, et al. Among authors: guo z. Ann Transl Med. 2015 Sep;3(16):230. doi: 10.3978/j.issn.2305-5839.2015.08.20. Ann Transl Med. 2015. PMID: 26539447 Free PMC article. Review. No abstract available.
2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma.
Gao M, Ge M, Ji Q, Cheng R, Lu H, Guan H, Gao L, Guo Z, Huang T, Huang X, Li X, Lin Y, Liu Q, Ni X, Pan Y, Qin J, Shan Z, Sun H, Wang X, Xu Z, Yu Y, Zhao D, Zhang N, Zhang S, Zheng Y, Zhu J, Li D, Zheng X, Chinese Association Of Thyroid Oncology Cato Chinese Anti-Cancer Association. Gao M, et al. Among authors: guo z. Cancer Biol Med. 2017 Aug;14(3):203-211. doi: 10.20892/j.issn.2095-3941.2017.0051. Cancer Biol Med. 2017. PMID: 28948061 Free PMC article. No abstract available.
2017 Chinese expert consensus on the clinical application of serum marker for thyroid cancer.
Gao M, Ge M, Ji Q, Cheng R, Lu H, Guan H, Cui W, Gao L, Gao Z, Guo L, Guo Z, Huang T, Huang X, Lin Y, Liu Q, Ni X, Qin J, Ren L, Shan Z, Sun H, Wang X, Xu Z, Yu Y, Zhang B, Zhao D, Zheng Y, Zhu J, Zheng X, Chinese Association Of Thyroid Oncology Cato China Anti-Cancer Association. Gao M, et al. Among authors: guo z, guo l. Cancer Biol Med. 2018 Nov;15(4):468-477. doi: 10.20892/j.issn.2095-3941.2018.0084. Cancer Biol Med. 2018. PMID: 30766757 Free PMC article. No abstract available.
A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer.
Zheng X, Xu Z, Ji Q, Ge M, Shi F, Qin J, Wang F, Chen G, Zhang Y, Huang R, Tan J, Huang T, Li S, Lv Z, Lin Y, Guo Z, Kubota T, Suzuki T, Ikezawa H, Gao M. Zheng X, et al. Among authors: guo z. Clin Cancer Res. 2021 Oct 15;27(20):5502-5509. doi: 10.1158/1078-0432.CCR-21-0761. Epub 2021 Jul 29. Clin Cancer Res. 2021. PMID: 34326132 Free PMC article. Clinical Trial.
Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer.
Lin Y, Qin S, Yang H, Shi F, Yang A, Han X, Liu B, Li Z, Ji Q, Tang L, Deng Z, Ding Y, Fu W, Xie X, Li L, He X, Lv Z, Ma Q, Shen Z, Guo Z, Chen Z, Cui Y, Tan J, Gao Z, Jing S, Lu K, Luo X, Zhang Y, Fang Y, Li Z, Cheng Y, Lei S, Luan S, Chen G, Wang G, Wu L, Liu L. Lin Y, et al. Among authors: guo z. Clin Cancer Res. 2023 Aug 1;29(15):2791-2799. doi: 10.1158/1078-0432.CCR-22-3613. Clin Cancer Res. 2023. PMID: 37184934 Clinical Trial.
Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial.
Chi Y, Zheng X, Zhang Y, Shi F, Cheng Y, Guo Z, Ge M, Qin J, Zhang J, Li Z, Zhou X, Huang R, Chen X, Liu H, Cheng R, Xu Z, Li D, Tang P, Gao M. Chi Y, et al. Among authors: guo z. Clin Cancer Res. 2023 Oct 13;29(20):4047-4056. doi: 10.1158/1078-0432.CCR-22-3406. Clin Cancer Res. 2023. PMID: 37594724 Free PMC article.
Safety and effectiveness of carbon nanoparticles suspension-guided lymph node dissection during thyroidectomy in patients with thyroid papillary cancer: a prospective, multicenter, randomized, blank-controlled trial.
Zhao J, Wang J, Cheng R, Qin J, Ai Z, Sun H, Guo Z, Zhang X, Zheng X, Gao M. Zhao J, et al. Among authors: guo z. Front Endocrinol (Lausanne). 2024 Jan 8;14:1251820. doi: 10.3389/fendo.2023.1251820. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38260138 Free PMC article. Clinical Trial.
21,250 results
You have reached the last available page of results. Please see the User Guide for more information.